Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1965 5
1966 12
1967 14
1968 13
1969 13
1970 20
1971 21
1972 15
1973 10
1974 9
1975 13
1976 10
1977 12
1978 14
1979 15
1980 14
1981 8
1982 13
1983 9
1984 3
1985 17
1986 23
1987 19
1988 27
1989 33
1990 32
1991 32
1992 39
1993 40
1994 39
1995 38
1996 62
1997 51
1998 77
1999 73
2000 69
2001 101
2002 90
2003 62
2004 80
2005 72
2006 69
2007 61
2008 58
2009 51
2010 59
2011 57
2012 56
2013 51
2014 45
2015 56
2016 50
2017 47
2018 39
2019 27
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,990 results
Results by year
Filters applied: . Clear all
Page 1
[A drug-resistant dyspepsia].
Voron T and Pernot S. Rev Prat 2018. PMID 30869257 French.
Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI, et al. Cochrane Database Syst Rev 2017 - Review. PMID 29161458 Free PMC article.
For this reason, decisions on whether to initiate or continue PPI therapy should be made based on an appropriate clinical indication. Therefore, we conducted a systematic review to evaluate whether PPI therapy provides symptomatic relief in FD. OBJECTIVES: To determine the efficacy of proton pump inhibitors in the improvement of global symptoms of dyspepsia and quality of life compared to placebo, H2 receptor antagonists or prokinetics, in people with functional dyspepsia. ...
For this reason, decisions on whether to initiate or continue PPI therapy should be made based on an appropriate clinical indication. …
Prokinetics in the Management of Functional Gastrointestinal Disorders
Quigley EMM. Curr Gastroenterol Rep 2017 - Review. PMID 28887755
Historically, disordered motility was also thought to contribute to a number of functional gastrointestinal disorders such as functional dyspepsia (FD) and irritable bowel syndrome (IBS). ...There is still an unmet need for an effective and safe prokinetic, but drug development in this area must be mindful of the challenges of the area and the need for selectivity for a given target receptor....
Historically, disordered motility was also thought to contribute to a number of functional gastrointestinal disorders such as functional …
Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis.
Jaafar MH, et al. Dig Dis Sci 2018 - Review. PMID 29192375
Overall, dyspepsia symptom improvement was significantly better with rebamipide compared to placebo/control drug (RR 0.77, 95% CI = 0.64-0.93; SMD -0.46, 95% CI = -0.83 to -0.09). ...CONCLUSION: Rebamipide is effective in organic dyspepsia and may improve symptoms in functional dyspepsia....
Overall, dyspepsia symptom improvement was significantly better with rebamipide compared to placebo/control drug (RR 0.77, 95% …
Efficacy of Jianpi Liqi therapy for functional dyspepsia: A meta-analysis of randomized, positive medicine-controlled trials.
Ye JT, et al. Medicine (Baltimore) 2019. PMID 31415353 Free PMC article.
BACKGROUND: We performed this meta-analysis to assess the efficacy and safety of Jianpi Liqi therapy (JLT), a traditional Chinese medicine therapy, in treating functional dyspepsia (FD). ...It may be an effective and safe therapy option for patients with FD. Though, more large-sample and strictly designed RCTs are needed to confirm our findings.PROSPERO registration number: CRD42019133241....
BACKGROUND: We performed this meta-analysis to assess the efficacy and safety of Jianpi Liqi therapy (JLT), a traditional Chinese med …
Management of Dyspepsia.
Feld L and Cifu AS. JAMA 2018. PMID 29715342
Dyspepsia.
Bolin TD and Korman MG. Med J Aust 1992 - Review. PMID 1447983
Dyspepsia: organic versus functional.
Oustamanolakis P and Tack J. J Clin Gastroenterol 2012 - Review. PMID 22327302
The prevalence of dyspepsia in the western world is approximately 20% to 25%. Dyspepsia can be divided into 2 main categories: "organic" and "functional dyspepsia" (FD). ...This review presents an update on the diagnosis of patients presenting with dyspepsia, with an emphasis on the pathophysiological and pathogenetic mechanisms of FD and the differential diagnosis with organic causes of dyspepsia. ...
The prevalence of dyspepsia in the western world is approximately 20% to 25%. Dyspepsia can be divided into 2 main categories: …
[Functional dyspepsia in primary care: therapeutic variety or helplessness?].
Labenz C, et al. MMW Fortschr Med 2019. PMID 30895511 German.
AIM: Evaluation of the frequency and the practical procedure in the diagnosis and therapy of functional dyspepsia in German GP surgeries. ...The frequency of patients with functional dyspepsia per week, the symptom spectrum complained of and the therapy strategy were inquired. ...
AIM: Evaluation of the frequency and the practical procedure in the diagnosis and therapy of functional dyspepsia in German GP …
Review article: endpoints used in functional dyspepsia drug therapy trials.
Ang D, et al. Aliment Pharmacol Ther 2011 - Review. PMID 21223343 Free article.
AIM: To focus on instruments and endpoints that have been used to evaluate the efficacy of therapeutic agents in functional dyspepsia (FD) trials, also considering the newly defined Rome III FD criteria. ...CONCLUSIONS: There is an urgent need to develop Rome III-based patient-reported outcomes for functional dyspepsia. Well-validated multi-dimensional questionnaires may serve as a guidance for this purpose, and could also be considered for use in ongoing clinical trials....
AIM: To focus on instruments and endpoints that have been used to evaluate the efficacy of therapeutic agents in functional dyspepsia
1,990 results
Jump to page
Feedback